{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:42:05Z","timestamp":1765888925668,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.vaccine.2022.06.025","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T22:13:20Z","timestamp":1655331200000},"page":"4496-4502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rubella antibodies in vertically and horizontally HIV-infected young adults vaccinated early in life and response to a booster dose in those with seronegative results"],"prefix":"10.1016","volume":"40","author":[{"given":"Beatriz Colla\u00e7o","family":"Araujo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Simakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Gustavo","family":"Munhoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana B","family":"Carmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina C\u00e9lia","family":"de Menezes Succi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Isabel","family":"de Moraes-Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.06.025_b0005","unstructured":"Pan American Health Organization. Measles\/Rubella Weekly Bulletin: Measles and Rubella Surveillance in the Americas 2018;24."},{"key":"10.1016\/j.vaccine.2022.06.025_b0010","article-title":"The Brazilian National Immunization Program: 46 years of achievements and challenges","volume":"36","author":"Domingues","year":"2020","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.vaccine.2022.06.025_b0015","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1016\/S0264-410X(03)00315-3","article-title":"Seroprevalence of rubella antibodies in the State of S\u00e3o Paulo, Brazil, 8 years after the introduction of vaccine","volume":"21","author":"Zanetta","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.025_b0020","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jir419","article-title":"Rubella vaccination of unknowingly pregnant women: The S\u00e3o Paulo experience, 2001","volume":"204","author":"Sato","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.025_b0025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.1973.03220330013003","article-title":"Immunologic Properties of RA27\/3 Rubella Virus Vaccine A Comparison With Strains Presently Licensed in the United States","volume":"225","author":"Plotkin","year":"1973","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.06.025_b0030","unstructured":"World Health Organization. United Nations International Children\u2019s Emergency Fund. Brazil: WHO and UNICEF estimates of immunization coverage: 2019 revision; 2020."},{"key":"10.1016\/j.vaccine.2022.06.025_b0035","series-title":"Red Book: 2018\u20132021 report of the committee on infectious diseases","article-title":"Rubella","author":"American Academy of Pediatrics","year":"2018"},{"key":"10.1016\/j.vaccine.2022.06.025_b0040","series-title":"Plotkin\u2019s vaccines","article-title":"Rubella Vaccines","author":"Reef","year":"2018"},{"key":"10.1016\/j.vaccine.2022.06.025_b0045","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/01.inf.0000128780.79145.5c","article-title":"Rubella immunization in human immunodeficiency virus type 1-infected children: Cause for concern in vaccination strategies","volume":"23","author":"Lima","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.025_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-3590-y","article-title":"Seroprevalence of measles vaccine antibody response in vertically HIV-infected children, in Morocco","volume":"18","author":"Haban","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.025_b0055","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1080\/21645515.2019.1599677","article-title":"Vaccination among HIV-infected, HIV-exposed uninfected and HIV-uninfected children: a systematic review and meta-analysis of evidence related to vaccine efficacy and effectiveness","volume":"15","author":"Adetokunboh","year":"2019","journal-title":"Hum Vaccin Immunother"},{"year":"2008","series-title":"The Immunological Basis for Immunization Series Module 11: Rubella Immunization, Vaccines and Biologicals","author":"World Health Organization Immunization","key":"10.1016\/j.vaccine.2022.06.025_b0060"},{"key":"10.1016\/j.vaccine.2022.06.025_b0065","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1093\/clinids\/7.Supplement_1.S53","article-title":"Aspects of Rubella Infection in Brazil","volume":"7","author":"Schatzmayr","year":"1985","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.025_b0070","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.vaccine.2014.03.078","article-title":"How advances in immunology provide insight into improving vaccine efficacy","volume":"32","author":"Slifka","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.025_b0075","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1080\/21645515.2015.1082014","article-title":"Vaccination of healthcare workers: A review","volume":"11","author":"Haviari","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2022.06.025_b0080","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1017\/S0950268800051281","article-title":"A model-based design of a vaccination strategy against rubella in a non-immunized community of Sao Paulo State","volume":"112","author":"Massad","year":"1994","journal-title":"Brazil Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2022.06.025_b0085","unstructured":"Secretaria de Saude do Estado de Sao Paulo. Rubeola: casos confirmados, coeficientes de incidencia e de letalidade (por 100000 hab) e obitos; 2022."},{"key":"10.1016\/j.vaccine.2022.06.025_b0090","doi-asserted-by":"crossref","first-page":"S608","DOI":"10.1093\/infdis\/jir357","article-title":"Historical analysis of birth cohorts not vaccinated against rubella prior to national Rubella Vaccination Campaign","volume":"204","author":"Segatto","year":"2011","journal-title":"Brazil J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.025_b0095","first-page":"1","article-title":"Guidelines for the use of antiretroviral agents in pediatric HIV infection","volume":"47","author":"Center for Disease Control and Prevention","year":"1998","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2022.06.025_b0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00148581-200507030-00001","article-title":"Facilitating Adherence to Highly Active Antiretroviral Therapy in Children with HIV Infection What Are the Issues and What Can Be Done?","volume":"7","author":"Pontali","year":"2005","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.vaccine.2022.06.025_b0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bjid.2012.06.006","article-title":"Usefulness of pharmacy dispensing records in the evaluation of adherence to antiretroviral therapy in Brazilian children and adolescents","volume":"16","author":"Santarem Ernesto","year":"2012","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.025_b0110","unstructured":"McLean HQ, FATJWGC for DC and P. Prevention of measles, rubella, congenital rubella syndrome, and mumps, in: 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, vol. 62, 2013, pp. 1\u201334."},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.025_b0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/INF.0000000000001831","article-title":"Immunity after Childhood Vaccinations in Perinatally HIV-exposed Children with and Without HIV Infection in Latin America","volume":"37","author":"Succi","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"19","key":"10.1016\/j.vaccine.2022.06.025_b0120","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.1073\/pnas.0901702106","article-title":"Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children","volume":"106","author":"Pensieroso","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.vaccine.2022.06.025_b0125","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.4049\/jimmunol.170.12.5965","article-title":"Deleterious Effect of HIV-1 Plasma Viremia on B Cell Costimulatory Function","volume":"170","author":"Malaspina","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2022.06.025_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009575","article-title":"Rapid progression is associated with lymphoid follicle dysfunction in SIV-infected infant rhesus macaques","volume":"17","author":"Wood","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2022.06.025_b0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2893.2005.00658.x","article-title":"Response to hepatitis A vaccine in HIV-positive patients","volume":"13","author":"Weissman","year":"2006","journal-title":"J Viral Hepatitis"},{"key":"10.1016\/j.vaccine.2022.06.025_b0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yapd.2012.04.017","article-title":"Immunization in Special Populations","volume":"59","author":"Miller","year":"2012","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.vaccine.2022.06.025_b0145","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/irv.12243","article-title":"HIV virological suppression influences response to the AS03-adjuvanted monovalent pandemic influenza A H1N1 vaccine in HIV-infected children","volume":"8","author":"Leahy","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"issue":"12","key":"10.1016\/j.vaccine.2022.06.025_b0150","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.4161\/hv.21827","article-title":"Immune reconstitution and vaccination outcome in HIV-1 infected children: Present knowledge and future directions","volume":"8","author":"Cagigi","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2022.06.025_b0155","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1086\/319591","article-title":"Effect of Highly Active Antiretroviral Therapy on the Serological Response to Additional Measles Vaccinations in Human Immunodeficiency Virus-Infected Children","volume":"32","author":"Berkelhamer","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.025_b0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/14760584.2019.1547195","article-title":"Effect of HIV exposure and timing of antiretroviral therapy initiation on immune memory responses to diphtheria, tetanus, whole cell pertussis and hepatitis B vaccines","volume":"18","author":"Simani","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2022.06.025_b0165","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1542\/peds.2005-2616","article-title":"Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: Loss of specific antibodies against attenuated vaccine strains and natural viral infection","volume":"118","author":"Bekker","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.06.025_b0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cimid.2017.07.006","article-title":"Predictors of humoral response to recommended vaccines in HIV-infected adults","volume":"54","author":"Tsachouridou","year":"2017","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.025_b0175","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1473-3099(20)30442-4","article-title":"Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis","volume":"21","author":"Schenk","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.025_b0180","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/IDR.S276362","article-title":"Will covid-19 lead to a resurgence of vaccine-preventable diseases?","volume":"14","author":"Khatiwada","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.vaccine.2022.06.025_b0185","unstructured":"Immunization Vaccines and Biologicals World Health Organization Team. Measles and rubella strategic framework 2021\u20132030. Geneva; 2020."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:19:07Z","timestamp":1759403947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22007745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":37,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0264410X22007745"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rubella antibodies in vertically and horizontally HIV-infected young adults vaccinated early in life and response to a booster dose in those with seronegative results","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}